Urteste S.A.
$44.50▲ 3.73%(+$1.60)
TickerSpark Score
42/100
▌ Weak
65
Valuation
20
Profitability
10
Growth
64
Health
50
Momentum
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a URT.WA research report →
52-Week Range43% of range
Low
$24.00
Current
$44.50
High
$72.20
Company Overviewwww.urteste.com
About the company
Urteste S. A. focuses on the investigation and development of diagnostic solutions designed to detect various forms of cancer.
- CEO
- Grzegorz Stefanski
- IPO
- 2021
- Employees
- 31
- HQ
- Gdansk, PL
Price Chart
-17.59% · this period
Valuation
- Market Cap
- $67.91M
- P/E
- -9.01
- P/S
- 136.64
- P/B
- 2.85
- EV/EBITDA
- -8.48
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -57.75%
- Op Margin
- -1771.43%
- Net Margin
- -1428.17%
- ROE
- -30.55%
- ROIC
- -23.29%
Growth & Income
- Revenue
- $22.00K · -98.78%
- Net Income
- $-5,981,000 · -64.72%
- EPS
- $-4.24 · -64.34%
- Op Income
- $-8,527,000
- FCF YoY
- 172.14%
Performance & Tape
- 52W High
- $72.20
- 52W Low
- $24.00
- 50D MA
- $44.06
- 200D MA
- $44.52
- Beta
- 0.22
- Avg Volume
- 586
Get TickerSpark's AI analysis on URT.WA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Coverage · URT.WA
Our URT.WA coverage
Recent articles, reports, and earnings notes.
On-Demand Research
No research on URT.WA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate URT.WA report →Internal Compare
Similar companies
Peers in the same neighborhood.